• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Johns Hopkins RheumTV

Show Search
Hide Search
  • About
  • Diseases
    • Ankylosing Spondylitis
    • Inclusion Body Myositis
    • Gout
    • Inflammatory Arthritis
    • Lupus
    • Lyme Disease
    • Myositis
    • Polymyositis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Scleroderma
    • Sjögren’s Syndrome
    • Vasculitis
  • Topics
    • Disease Information
    • Exercise Tips
    • Lifestyle Tips
    • Medication Education
    • Patient Education
    • Biologic Medication Education
    • Corticosteroids
  • Contact Us
Home / RheumTV / Scleroderma Associated Myopathy – Treatment

Scleroderma Associated Myopathy – Treatment

The treatment for Scleroderma Associated Myopathy is still largely unknown because there is not enough information about the disease. The Johns Hopkins Rheumatology Division is working to understand more about this kind of Myopathy. In this video, Dr. Julie Paik, Assistant Professor of Medicine at Johns Hopkins Rheumatology, explains the complicated nature of treating this disease.

In This Video

Julie Paik MD, MHS

Dr. Paik is an Assistant Professor of Medicine in the Division of Rheumatology. Dr. Paik’s clinical and research interests are focused on neuromuscular manifestations of autoimmune diseases, particularly in the areas of myositis and scleroderma.

Primary Sidebar

Related Content

  1. Scleroderma Associated Myopathy – Lifestyle Options
  2. Lyme Disease Prognosis Lyme Disease Prognosis
  3. Scleroderma Associated Myopathy – Overview

Johns Hopkins Medicine

© 2025 Johns Hopkins Rheumatology
Patient Privacy